Notice Number: NOT-DA-18-044

Key Dates
Release Date: September 24, 2018

Issued by
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

This notice informs the community that PA-18-917 - Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) has been opened to accept application for the October/November 5, 2018 standard due dates. All other aspects of the opportunity remain unchanged.

Current reads:

Open Date (Earliest Submission Date) December 7, 2018

Changed to:

Open Date (Earliest Submission Date) September 24, 2018

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Yu (Woody) Lin, MD, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1318
Email: ylin1@nida.nih.gov